SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2, and PDGFR at a rate of 97%, 65%, and 55%, respectively, at the concentration of 10 µM in biochemical kinase assays.
Molecular Weight:
415.37
Purity:
99.83%
CAS Number:
[1125780-41-7]
Formula:
C21H16F3N3O3
Target:
PDGFR|||FGFR|||VEGFR
T1895
* VAT and and shipping costs not included. Errors and price changes excepted
